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ABSTRACT 
Christiansen, L.I, 2002. Preparation, analysis and cholesterol lowering effect of a novel microcrystalline 
β-sitosterol suspension in oil and phase behaviour of β-sitosterol with cholesterol.  
Dissertationes Biocentri Viikki Universitatis Helsingiensis 11/2002, pp. 54 
ISBN 952-10-0508-4 (print) ISBN 952-10-0509-2 (pdf) ISSN 1239-9469 
Few efforts have been made to formulate preparations suitable for oral administration of 
free plant sterols. Technological problems are associated with free crystalline plant sterols 
due to their poor solubility in oil and insolubility in water and relatively large daily doses. 
Crystallisation of anhydrous and hydrated cholesterol crystals in several environments, 
including physiological conditions, has been widely studied. On the contrary, few structural 
studies concerning free crystalline β-sitosterol or other plant sterols have been published.  
In the present study, preparation and analyses of a novel microcrystalline β-sitosterol 
suspension in oil and its cholesterol lowering effect is described. In addition, different 
pseudopolymorphic forms of β-sitosterol are characterised and phase behaviour of a β-
sitosterol-cholesterol binary system in aqueous as well as in non-aqueous environments is 
studied. 
β-sitosterol was observed to exist in three different pseudopolymorphic forms with 
different water contents: anhydrated, hemihydrated and monohydrated crystals. β-sitosterol 
suspensions in oil were prepared by adding water to supersaturated sterol in oil solutions. 
Addition of water to the composition resulted in a decrease in sterol solubility in oil and in 
the formation of monohydrated needle-shaped crystals instead of plate-like anhydrous 
crystals. Needle-shaped particles formed structured suspensions with shear thinning 
behaviour. A high sterol concentration resulted in high supersaturation and thus in 
formation of microcrystalline (crystal length ≈ 10 µm) crystals.  
Microcrystalline β-sitosterol suspension in oil lowered effectively serum cholesterol 
levels in hypercholesterolemic subjects and the effect was comparable to earlier results with 
fat-soluble esterified plant sterols and stanols. A daily dose of 1.5 g plant sterol in 
microcrystalline form was enough to reach the significant cholesterol lowering effect. 
β-sitosterol and cholesterol exhibited solid solubility over a wide range of different 
proportions. The crystal structure, thermal behaviour and habit of the mixed crystals varied 
with composition. Cholesterol, β-sitosterol, and the mixed crystals formed anhydrous 
crystals in the absence of water and monohydrated crystals in the presence of water. The 
presence of β-sitosterol decreased the total sterol solubility in the aqueous system. Thus, 
the presence of plant sterols may facilitate the crystallisation of cholesterol in physiological 
environments. On the basis of the present study, it is quite evident that crystallisation of 
sterols in the lumen of intestine may lead to restricted absorption of cholesterol and thus 
cause a decrease in serum cholesterol levels.  
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 1 INTRODUCTION 
Sterols are essential compounds for all eukaryotes. Whereas mammalian cells generally 
contain one major sterol, cholesterol, sterols in plants are always present as mixtures of 
different plant sterols (Yeagle, 1985; Hartmann, 1998). So far, over 200 different plant 
sterol molecules have been found in nature. Sterols are cell membrane components that 
regulate the membrane fluidity and permeability and can participate in the control of 
membrane-associated metabolic processes. Sterols are also precursors for several other 
compounds involved in important cellular and 
developmental processes in animals and higher 
plants. Sterol molecules consist of a planar 
tetracyclic skeleton, a hydroxyl group and a 
hydrophobic tail (Fig. 1). Most of the sterol 
molecule is hydrophobic, but the polar hydroxyl 
group gives the molecule an amphiphilic character.  
OH
Figure 1. Molecular structure of 
cholesterol 
Although cholesterol is essential for normal cell growth and function, a high 
concentration of cholesterol in serum and other tissues can be harmful. Epidemiological, 
post mortem, and angiographic studies have established a causal relation between elevated 
serum cholesterol levels (> 5 mmol/l) and genesis of atherosclerosis and thus 
cardiovascular diseases, which are the major cause of morbidity and mortality in western 
societies (Levine et al., 1995; Sullivan, 2002). In addition to atherosclerotic lesions, elevated 
cholesterol levels play an important role in the genesis of cholesterol gallstones (Strasberg, 
1998). Cholesterol is practically insoluble in water and thus it is associated with different 
vehicles in the human body. Cholesterol is either solubilised in bile salt micelles or 
associated with different phospholipid vesicles or with lipoprotein particles as free 
cholesterol or as cholesterol fatty acids esters (Montet and Gerolami, 1978; Staggers et al., 
1990; Mensink et al., 1998). When the cholesterol concentration exceeds the solubilising 
capacity of these vehicles, deposition of cholesterol crystals may occur. Solid cholesterol 
crystals can be found in pathological lesions such as in atherosclerotic lesions and in 
gallstones (Armirand and Small, 1968; Lundberg, 1985; Small and Shipley, 1974). 
Plant sterols are structurally related to cholesterol, and the most common plant 
sterols, β-sitosterol, campesterol and stigmasterol differ from cholesterol by an additional 
ethyl or methyl group and/or a double bond in the side chain (Fig. 2). Saturated plant 
stanols, such as β-sitostanol, are formed when the double bond in the B ring is saturated. 
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 Although a typical dietary intake of plant sterols is almost equal to a dietary intake of 
cholesterol only small amounts of plant sterols are commonly detected in human plasma 
(Jones et al., 1997). Serum β-sitosterol and campesterol levels are normally about 1/1000 
and 2/1000 of that of cholesterol, respectively (Kuksis, 2001). Increased plasma levels of 
plant sterols can occur in individuals who suffer from sitosterolemia, which is an extremely 
rare inherited disorder caused by increased intestinal absorption and reduced hepatic plant 
sterol excretion (Miettinen, 1980). In sitosterolemic patients, up to 30% of serum and bile 
sterols are plant sterols. Similarly to cholesterol, abnormally high plasma plant sterol 
concentration has been found to be atherogenic (Glueck et al., 1991). 
OH OH
OH OH  
(A) (B) 
(C) (D) 
 
Figure 2. Structures of campesterol (A), β-sitosterol (B), stigmasterol (C) and β-sitostanol (D) 
The recent interest in plant sterols, especially in β-sitosterol and its saturated form β-
sitostanol, is due to their cholesterol lowering effect, which is observed when additional 1-3 
g plant sterols or stanols are added to diets. The cholesterol lowering effect of plant sterols 
has been known since the 1950’s, but technical problems such as poor solubility of these 
materials and discovering more effective cholesterol lowering agents, have restrained the 
interest in them. In the 1990’s two functional food preparations containing plant sterols 
and stanols as active ingredients came on the European market (Law, 2000). The promising 
cholesterol-lowering results of these products have raised the common interest in plant 
sterols and stanols.  
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 Free plant sterols and stanols are crystalline materials, which are insoluble in water, 
and their solubility in edible fats and oils is low (Jandacek et al., 1977; Mattson et al., 1977). 
The physico-chemical properties of free plant sterols and stanols and relatively large daily 
doses limit their applicability in several preparations suitable for oral administration. 
Though the cholesterol lowering effect of plant sterols and stanols has been extensively 
studied, few structural studies concerning these have been published. 
There are several hypotheses of the mechanism by which plant sterols lower serum 
cholesterol levels. Because the chemical structure of plant sterols is very similar to that of 
cholesterol, the introduction of plant sterols into the human body may affect the phase 
behaviour of cholesterol such as solubility and crystallisation.  
1.1 PRINCIPLES OF PHASE BEHAVIOUR  
1.1.1 Phase behaviour of single substances 
A phase of a substance is a form of matter that is uniform in terms of chemical 
composition and physical state (Atkins, 1998). A single substance can appear in several 
physical states, such as in solid, liquid and gas phases, depending on temperature and 
pressure. A phase diagram of a substance 
shows the regions of pressure and 
temperature at which its various phases 
are thermodynamically stable (Fig. 3). The 
lines separating these regions show the 
values of temperature and pressure at 
which the phases are in equilibrium. In 
equilibrium, the chemical potential of a 
substance is the same throughout a 
sample, regardless of how many phases are 
present. A phase transition, the 
spontaneous conversion of one phase into 
another phase, occurs at a characteristic 
temperature for a given pressure. The 
direction of a spontaneous change is in the 
direction of decreasing chemical potential. 
Figure 3. A common temperature-pressure phase 
diagram of a single compound (modified from 
Atkins, 1998) 
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 The liquid-gas boundary of a phase diagram shows how the vapour pressure of a 
liquid varies with temperature, and how the boiling temperature of a liquid varies with 
pressure. Similarly, the solid-gas boundary shows the effect of temperature on the 
sublimation vapour pressure of the solid. The vapour pressure of liquids and solids is the 
pressure of vapour in equilibrium with the more condensed liquid and solid phases. The 
solid-liquid boundary in a phase diagram shows how the pressure affects the melting point 
of the solid and the freezing point of the liquid. In the solid state, phase transitions such as 
different polymorph interconversions, desolvation of solvates and conversion of crystalline 
solids into amorphous forms can occur (Vippagunta et al., 2001).  
In a phase diagram of a substance, there is a point called a triple point of a substance, 
where the three phase boundaries meet. At this single definite temperature and pressure 
(temperature T3, pressure P3) the three different phases (solid, liquid and gas phases) of a 
substance simultaneously co-exist in equilibrium. Above a certain temperature and pressure 
combination, called critical temperature (Tc) and pressure (Tp) of a substance, a single 
uniform phase, called supercritical fluid, exists.  
1.1.1.1 Solid state  
A crystalline solid has a highly ordered structure called a crystal lattice (Cullity, 1978). In 
crystal lattices, atoms and molecules are arranged periodically in three dimensions. The 
basic repeating unit in the crystal lattice is called a unit cell.  
In the solid state, materials can crystallise in different ways forming different 
polymorphic forms. Polymorphism is defined as an ability of a compound to crystallise in 
more than one crystal form, each having its own packing arrangement of atoms or 
molecules in the crystal structure (Haleblian and McCrone, 1969). Polymorphs have 
different physical properties such as melting point, enthalpy of fusion, density, solubility 
and dissolution rate. In addition, different polymorphs usually exhibit different habits. 
Based on differences in the thermodynamic properties, polymorphs are classified as either 
enantiotropes or monotropes (Vippagunta et al., 2001; Grant, 1999). Enantiotropic 
polymorphs are stable over a certain temperature range and pressure and a reversible 
polymorphic transition can be observed at a definite transition temperature. Different 
polymorphs of a substance are called monotropes when only one polymorph is stable at all 
temperatures below the melting point and all other polymorphs are always unstable. 
In addition to crystalline state, solids can occur in an amorphous state, which does 
not possess a regular structure. Similarly to a crystalline solid, an amorphous solid may have 
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 short-range molecular order, but unlike a crystalline solid, an amorphous solid has no long-
range order of molecular packing (Yu, 2001). The amorphous state, also called a glass state, 
is less stable physically than the corresponding crystal form. The glass forming ability of a 
substance can originate either from a crystalline state that is not substantially more stable 
than the amorphous form or from a slow crystallisation rate that allows a material to 
become a “frozen liquid” by vitrifying without crystallisation. Crystalline materials can be 
made amorphous by deliberately preventing crystallisation by several methods including 
rapid freezing of the liquid state. The characteristic temperature below which melted solids 
must be cooled to form a glass is the glass transition temperature (Tg) (Guillory, 1999). 
Below Tg material is considered to be mechanically in the solid state, though lacking 
structural order. 
Solvates are molecular complexes that contain solvent incorporated in the crystal 
structure of a compound. When water is the solvent of crystallisation, solvates are called 
hydrates. Crystals that contain no solvent of crystallisation are called anhydrates. The term 
pseudopolymorph is used to distinguish solvates from polymorphs. Crystalline hydrates can 
be classified into three categories: isolated site hydrates, channel hydrates and ion-
associated hydrates (Vippagunta et al., 2001). The isolated site hydrates represent the 
structures with water molecules isolated from direct contact with other water molecules by 
intervening substance molecules. When water molecules included in the lattice lie next to 
other water molecules of adjoining unit cells along the axis of the lattice forming channels 
throughout the crystal, the hydrate is called a channel hydrate. In the ion-associated 
hydrates the metal ions are coordinated with water.  
1.1.1.2 Liquid state  
The structure of liquids lies somewhere between the completely disordered gaseous state 
and the highly ordered crystalline state. Liquids possess short-range order but lack long-
range order (Chang, 1981). Normal liquids are isotropic, which are similar in all directions.  
In addition to isotropic liquids, anisotropic liquid crystalline structures may occur in 
liquids.  A liquid crystalline phase, also called a mesophase, is a phase with a degree of 
order intermediate between the liquid and solid phases (Hamley, 2000). Liquid crystal 
phases can be divided into two classes: thermotropic and lyotropic liquid crystal phases. 
Substances form thermotropic liquid crystalline phases in a certain temperature range. In 
contrast, lyotropic liquid crystal phases form in solutions, and concentration of the 
solutions controls the liquid crystallinity in addition to temperature. The most important 
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 property of liquid crystal phases is that the molecules have long-range orientational order. 
Some liquid crystals also exhibit translational order. 
1.1.1.3 Gas phase  
The gaseous state is characterised by complete randomness (Chang, 1981). In the gas state 
the molecules of a compound are widely separated from each other, and unlike in liquid 
and solid states, the movement of molecules is nearly unaffected by intermolecular forces 
(Atkins, 1998). Intermolecular forces may be important at high pressures when molecules 
are close together and at low temperatures, when the molecules travel at low speeds. 
Repulsive forces between molecules are short-range interactions and are important only 
when molecules are almost in contact, such as at high pressures. Attractive forces have 
longer range and are effective over several molecular diameters.  
1.1.2 Phase behaviour of mixtures 
In mixtures, the principal properties of substances, such as molar volume and chemical 
potential, are different than in pure substances because the environment of each molecule 
changes as the composition of the mixture changes (Atkins, 1998). In the gas state all the 
compounds are miscible with each other, because the interaction with the molecules is rare 
and because of the rapid movement of molecules. In liquid and solid states, there are 
always interactions between molecules. In a mixture of substances A and B, the interactions 
A-A, A-B and B-B are all different. Thus, in liquid and solid phases different compounds 
may be either miscible or immiscible depending on the nature of the intermolecular 
interactions. Miscible components form a single homogenous phase or immiscible 
compounds exhibit several distinct phases. Partially miscible compounds are miscible only 
over a certain range of 
compositions. 
1.1.2.1 Solid solutions 
If materials are mutually soluble 
in both liquid and solid states, 
they may crystallise together in a 
homogenous one-phase system 
called a solid solution. Solid 
solutions may be substitutional, 
Figure 4. Formation of a substitutional (left and 
interstitial (right) solid solutions (modified from Chiou 
and Riegelman, 1971) 
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 when the molecules of one compound replace the molecules of the other in the crystal 
lattice or interstitial, where the molecules of one compound sit within the crystal lattice of 
the other without disrupting it (Chiou and Riegelman, 1971) (Fig. 4).  
When two components are miscible in the solid state in all proportions, they form a 
continuous solid solution. When the solvent is capable of dissolving the other component 
only to a certain degree, components form discontinuous solid solutions. In theory, the 
lattice energy of a continuous solid solution in various compositions should be greater than 
that of pure components, because the strength of the bond between the two different 
components should be greater than that between the same species of molecules. 
1.1.2.2 Eutectic mixtures 
When two compounds are immiscible, 
phase separation occurs and in the solid 
state, they crystallise as separate 
components. When two components 
are completely miscible in the liquid 
state, but negligible soluble in the solid 
state they may form a eutectic mixture. 
A eutectic mixture is regarded as an 
intimately blended physical mixture of 
two crystalline components (Rastogi and 
Bassi, 1964; Chiou and Riegelman, 
1971). A typical temperature-
composition diagram of a eutectic 
mixture of hypothetical compounds A and B is described in Fig. 5. When compound B is 
added to compound A, the melting point of the A is depressed with increasing B 
proportion and vice versa. With a certain eutectic composition, the materials disturb each 
other’s crystallisation maximally and the mixture exhibits a melting point minimum. The 
eutectic point is the temperature at which two solid phases are in equilibrium with the 
liquid phase. 
Figure 5. Phase diagram of a eutectic mixture 
(modified from Ford and Timmins, 1989) 
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 1.1.3 Methods for analysing phase behaviour of substances 
1.1.3.1 Thermal analysis 
Thermoanalytical methods examine a parameter of a system as a function of temperature 
(Giron, 1986).  The two useful thermoanalytical methods in phase analyses are differential 
scanning calorimetry (DSC) and thermogravimetric analysis (TGA). In DSC, the parameter 
is the heat flow in and out of the sample and in TGA the measured parameter is the weight 
change of the sample.  
All the phase transitions 
where energy changes are involved 
may be measured by DSC. 
Thermal reactions may be 
endothermic (melting, boiling, 
sublimation, vaporisation, 
desolvation, solid-solid phase 
transitions) or exothermic 
(crystallisation) (Brittain, 1999). 
Endothermic reactions require 
added energy and exothermic 
reactions release energy. In the DSC analysis, a sample pan and an empty reference pan are 
heated linearly and they will initially be at the same temperature. If an endothermic or 
exothermic phase change occurs, energy is either used or released by the sample. The 
temperature difference is observed and the difference is corrected by adding compensation 
energy to maintain equal temperature in both pans. The result of the analysis is heat flow as 
a function of temperature (Fig. 6). In addition to qualitative information on transition 
temperatures, quantitative data on heats of transitions may be determined with DSC 
according to the area under the curve values of the transition peaks.  
Figure 6. Typical DSC thermogram of a glassy polymer 
showing glass transition, recrystallisation and melting 
transitions (modified from Ford and Timmins, 1989) 
 In TGA, the thermally induced weight loss of a material is measured as a function of 
applied temperature (Brittain, 1999). Thus, TGA is restricted to transitions that involve 
either a gain or loss of mass, and it is most commonly used to study desolvation processes. 
TGA is a useful tool for separating desolvation transitions from other endothermic events 
in DSC and differentiation and characterisation of solvates.  
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 1.1.3.2 X-ray diffraction 
The x-ray diffraction analysis provides information on ordered structures and it is therefore 
the primary method to determine structures of crystalline and liquid crystalline phases 
(Brittain, 1999; Hamley, 2000). With the aid of x-ray diffraction analysis, the crystal 
structure of the solid or liquid crystalline phases can be solved and different polymorphs 
can be identified. In addition, x-ray diffraction provides quantitative information about  the 
mixtures of different crystal forms and about the degree of crystallinity of the sample.  
The X-ray diffraction technique is based on Bragg’s law, which describes the 
diffraction of a monochromatic x-ray beam impinging on a plane of atoms (Cullity, 1978). 
In ordered structures, such as crystal lattices, atoms and molecules are arranged in sets of 
planes, which have various values of interplanar spacing (d). Parallel incident rays strike a 
plane at angle θ and are then diffracted at the same angle. The scattering angles of the 
diffracting beams are correlatable to the spacings between planes of molecules in the crystal 
lattice according to Bragg’s law: 
θλ sin2dn =  
where n = order of the diffraction 
pattern, λ = wavelength of the 
incident beam, d = distance between 
the planes and θ = angle of beam 
diffraction. According to Bragg’s law, 
at small θ  values wide-range 
structures are observed. Similarly, the 
larger the θ  values, the smaller the 
corresponding spacing in the crystal 
lattice is. Thus, the small-angle x-ray 
scattering (SAXS) (< 5° (2θ) method is 
used to examine wide range structures 
such as liquid crystals. Wide-angle x-
ray scattering (WAXS) is used to 
examine short-range order structures 
such as crystalline solids. 
Figure 7. X-ray diffraction patterns of (a) MCT 
(medium chain triglyceride) oil in liquid state, and 
two enantiotropic polymorphs of solid cholesterol 
anhydrate: (b) at 25°C and (c) at 60°C 
(Christiansen et al., unpublished data) 
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 If atoms are arranged randomly in space, as in a gas phase, scattering of x-rays occurs 
in all directions. If atoms are arranged periodically in space, as in a crystalline structure, the 
diffracted beam is composed of a large number of scattered rays mutually reinforcing one 
another. Each crystalline material has a unique diffraction pattern in which the peaks have 
certain positions and relative intensities (Haleblian and McCrone, 1969). Amorphous 
materials and liquids exhibit the classical diffuse “halo” x-ray diffraction rather than the 
sharp peaks observed in the pattern of a crystalline substance (Fig. 7).  
1.1.3.3 Near infrared spectroscopy 
The near infrared (NIR) region of the electromagnetic spectrum is from 760 to 2600 nm. 
The theory of NIR spectroscopy and its applications are described in detail e.g. by Blanco 
et al. (1998). Absorption bands observed in this region arise from overtones of stretching 
vibrations involving functional groups with hydrogen atoms or combinations involving 
stretching and bending modes of vibration of these groups. Most of the NIR bands 
observed involve hydrogen to heteroatom bonds. For infrared light to be absorbed, its 
wavelength (i.e. energy) must be the same as fundamental vibrational transitions in the 
molecules concerned. The low molar absorptivity of absorption bands in the NIR region 
permits the operation in the reflectance mode and hence recording of spectra for solid 
samples with minimal or no sample pre-treatment. Reflectance spectroscopy measures the 
light reflected by the sample.  The baseline of the NIR absorbance spectra is affected by 
the differences in particle size and shape distributions, bulk density and texture of the 
surface. This effect can be minimized e.g. by calculating the second derivative of the 
absorbance. Overlapping bands can also be separated with this treatment, and a more 
precise analysis of these bands can be made. 
The dependence of the NIR signal on both the chemical composition and some 
physical properties of the sample permit not only identification of substances, but also the 
determination of non-chemical parameters, such as polymorphic forms (Blanco et al., 
1998). NIR spectroscopy is useful for detecting hydrates and adsorbed water, since water 
exhibits strong characteristic absorption bands in the NIR region (Curcio and Petty, 1951).  
Previously, NIR has been applied to studying the nature of water-solid interactions using 
various materials such as lactose and theophylline (Buckton et al., 1998; Luukkonen et al., 
2001; Räsänen et al., 2001). With the aid of NIR spectrometry, different energetic states of 
water molecules in the crystals are seen as absorption maxima in different wavelengths. 
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 1.1.3.4 Optical microscopy 
Microscopy is a tool by which a visual image of a sample can be created. Optical 
microscopy is suitable for examining particles from 1 µm up to 1 mm (Staniforth, 1988). 
Microscopy is an important tool for characterising polymorphs and solvates, since the 
observable habits of differing crystal structures are usually different (Haleblian, 1975). In 
addition, crystallisation process parameters such as the degree of supersaturation, rate of 
cooling, agitation and nature of the used solvent may affect the crystal habit. 
1.2 CHOLESTEROL HOMEOSTASIS IN THE HUMAN BODY 
Cholesterol homeostasis in the human body is maintained by balancing cholesterol 
absorption, endogenous synthesis and excretion. Important regulatory mechanisms involve 
(1) intestinal cholesterol absorption, (2) hepatic cholesterol synthesis, (3) conversion of 
cholesterol to bile acids in the liver, (4) biliary secretion of free cholesterol and (5) fecal 
elimination of steroids of cholesterol origin (Kesäniemi and Miettinen, 1988). 
1.2.1 Intestinal absorption  
The average dietary intake of cholesterol in western countries is 300-500 mg per day 
(Sehayek et al., 1998). In addition to dietary cholesterol, 800-1200 mg cholesterol is 
excreted daily from the biliary duct into the intestine. A variable proportion of dietary 
cholesterol is esterified (on average 10-15%) with fatty acids, but all biliary cholesterol is 
non-esterified and is incorporated into bile salt-phospholipid micelles (Shen et al., 2001). 
The efficacy of cholesterol absorption (percent cholesterol absorption) in normal 
healthy individuals is on average 50% of the ingested amount (Bosner et al., 1999). 
Individual subjects have marked differences in cholesterol absorption (ranging from 29% 
to 80%), but variability in repeated cholesterol absorption studies in the same individual is 
small (Bosner et al., 1993; Bosner et al., 1999).  
A decrease in the percent cholesterol absorption with increasing dietary cholesterol 
has been observed in both animal and human studies (Ellegård and Bosaeus, 1994; Sehayek 
et al., 1998; Ostlund et al., 1999). Increased dietary cholesterol intake increases biliary 
cholesterol concentration, which in turn has been found to decrease the absorption of 
dietary cholesterol. The saturation of cholesterol absorption by either increased dietary 
cholesterol ingestion or increased excretion of biliary cholesterol into the intestine occurs 
by saturation of solubilisation capacity of the mixed micelles (Sehayek et al., 1998).  
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 1.2.1.1 Luminal events 
Dietary lipids contain 97% triglycerides and small amounts of phospholipids and 
cholesterol (Thomson et al., 1993). Emulsification of dietary fat occurs mainly in the 
stomach (Armand et al., 1996). The lipid emulsion enters the small intestine as fine 
droplets, 1-100 µm in size. The particle size of the fatty droplets is further decreased and 
thus the surface area of the droplets is enlarged in the intestine because of detergent 
properties of bile salts and digestive products from the stomach. Enzymatic hydrolysis of 
dietary lipids occurs at the interface between oil and aqueous phases (Shen et al., 2001). 
Cholesterol esters of dietary origin must be hydrolysed by pancreatic cholesterol esterase 
enzyme before free cholesterol can be absorbed (Howles et al., 1996).  
In the intestinal lumen, the brush-border membrane of enterocytes is separated from 
the bulk fluid phase by an unstirred water layer (Thomson et al., 1993; Shen et al., 2001). 
Because the solubility of cholesterol and several other components of dietary fat is 
extremely low in water, solubilisation of lipids in the water phase is needed.  The passage 
through the unstirred water layer is the rate-limiting step in the intestinal absorption of 
cholesterol (Westergaard and Dietschy, 1976). Bile salts, products of triglyceride digestion, 
phospholipids and cholesterol form multimolecular aggregates called mixed micelles. 
According to a theory presented by Hofmann and Borgström (1964), duodenal lipids 
distribute between two phases: an oily phase and an aqueous micellar phase. Esterified 
sterols are enriched in the oil phase while cholesterol in the micellar phase is mainly free 
unesterified cholesterol (Miettinen and Siurala, 1971). Later studies have revealed that the 
physical state of the intestinal lipids in the aqueous phase is rather complex (Borgström, 
1985, Hernell et al., 1990, Staggers et al., 1990). Above the critical micelle concentration of 
the bile salts, large disc-like micelles are formed which are more or less saturated with 
lipids. If the amount of lipids in the aqueous phase increases above the capacity of micellar 
solubilisation, liquid crystalline phospholipid bilayer vesicles will be formed. When the 
phospholipid vehicles are saturated with cholesterol, monohydrated cholesterol crystals 
may precipitate (Staggers et al., 1990). 
Any condition that results in a reduced concentration of bile salts within the 
intestinal lumen will cause impaired micellar solubilisation and absorption of cholesterol 
and other lipids. For example, unabsorbable anion-exchange resins such as cholestyramine 
and cholestipol bind bile acids in the intestine, thus favouring their fecal loss and reduction 
of the body pools of cholesterol (Sirtori et al., 1991). Physiological pH changes of chyme 
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 during transit through the duodenum have a pronounced effect on the distribution of fatty 
acids and cholesterol between micellar and oil phases (Chiniwa and Linscheer, 1984). 
Changes in pH can affect micellar solubility of cholesterol in bile salt micelles and thus the 
intestinal absorption. In addition, intestinal transit time (Ponz de Leon et al., 1982; 
Koivisto and Miettinen, 1986) and intestinal content viscosity (Carr et al., 1996) can affect 
the absorption of cholesterol.   
1.2.1.2 Uptake by intestinal epithelium 
Successful solubilisation of lipids in the mixed micelles permits the lipid digestion products 
to diffuse through the unstirred water layer onto the surface of the intestinal epithelium 
(Simmonds, 1972; Watt and Simmonds, 1976). Within the unstirred water layer an acidic 
microenvironment aids the dissociation of lipid monomers from the micelles (Thomson et 
al., 1993). Cholesterol is absorbed in the upper small intestine as single molecules, whereas 
the vehicles for micelle formation, bile salts, are reabsorbed mainly in the terminal small 
intestine (ileum).  
It is probable that both protein-mediated and passive cholesterol absorption by the 
small intestine brush border membrane occurs (Thurnhofer et al., 1991). Recent studies 
have showed that the cholesterol absorption transporters can be blocked specifically by 
chemical entities, which interact with the transporters (Detmers et al., 2000; Hernandez et 
al., 2000). A specific cholesterol transporter is located in the brush-border membrane and it 
acts by carrying cholesterol from the mixed micelles into the membrane. The processes that 
control cholesterol absorption appear to be rather specific since structurally related sterols, 
such as plant sterols, are less efficiently absorbed (Salen et al., 1970; Wilson and Rudel, 
1994). Genetic factors, such as apolipoprotein E (apoE) polymorphism, influence the 
efficacy of cholesterol absorption as well as metabolism and thus affect serum total and 
LDL-cholesterol levels (Ehnholm et al., 1986; Kesäniemi et al., 1987; Kesäniemi and 
Miettinen, 1988).  
After entering the enterocytes, cholesterol is transported to endoplasmic reticulum by 
cytosolic sterol carrier proteins (Tso and Balint, 1986). In the small intestine epithelium 
most of the cholesterol is esterified with fatty acids by two enzymes, cholesterol esterase 
and acetyl-CoA cholesterol acyltransferase (ACAT). The intestine secretes cholesterol in 
triglyceride-rich chylomicrons into the lymph. Chylomicrons are spherical lipoprotein 
complexes with a hydrophobic core composed of triglycerides and cholesterol esters and 
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 with a surface composed of phospholipids, free cholesterol and apoproteins synthesised by 
the enterocytes. 
A considerable amount of research has been focused on the development of 
effective ACAT-enzyme inhibitors and several potent inhibitors have been developed and 
tested (Roth, 1998).  ACAT is the primary enzyme responsible for esterification of 
cholesterol in the enterocytes, and enzyme inhibitors have been promising in blocking 
cholesterol absorption in animal models. Because the cholesterol-lowering effect of ACAT 
inhibitors in clinical trials has been modest, esterification of intracellular cholesterol does 
not seem to play an obligatory role in cholesterol absorption. 
1.2.2 Endogenous synthesis 
The main site of the cholesterol synthesis is the liver (Stryer, 1995; Li and Parish, 1998). 
Appreciable amounts are also synthesised by the intestine. In addition, other tissues are 
able to synthesise cholesterol, but the primary cholesterol source of other tissues than the 
liver and the intestine is plasma LDL cholesterol particles. The rate-limiting enzyme in the 
cholesterol biosynthesis is 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMG-CoA 
reductase) (Fig. 8).   
The rate of cholesterol synthesis in the liver is 
highly dependent on the amount of cholesterol 
absorbed in the intestine (Kesäniemi and Grundy, 
1984; Kesäniemi and Miettinen, 1988). Inhibition of 
the cholesterol absorption will decrease the quantity 
of cholesterol returning to the liver with 
chylomicron remnants. As a result of the reduction 
of liver cholesterol, a compensatory increase in the 
synthesis of LDL receptors takes place. 
Consequently, the uptake of LDL from circulation 
is enhanced and a decrease in serum LDL and total 
cholesterol is observed. On the contrary, 
overloading of the liver cells with cholesterol results in reduction of hepatic cholesterol 
synthesis regulated by the HMG-CoA reductase enzyme, in decreased activity of hepatic 
LDL receptors, in lowered receptor mediated removal of LDL from plasma and 
subsequently in increased plasma LDL levels (Kesäniemi and Miettinen, 1988). This 
feedback regulation is mediated by changes in the activity of HMG-CoA reductase. On the 
acetyl-CoA
HMG-CoA 
reductase 
mevalonic 
acid 
squalene
lanosterol
cholesterol
Figure 8. Steps of cholesterol biosynthesis 
(Li and Parish, 1998) 
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 other hand, low hepatic cholesterol and bile acid synthesis and/or diminished biliary 
cholesterol secretion leads to a lower intestinal load of cholesterol and thus enhances the 
intestinal absorption of cholesterol and vice versa. 
Inhibitors of HMG-CoA reductase are a class of cholesterol lowering agents, which 
decrease the synthesis of cholesterol (Sirtori et al., 1990). In cells, the inhibition of the 
reductase leads to a marked increase in HMG-CoA reductase with no significant 
production of cholesterol and to an increase in LDL receptors on the cell surfaces draining 
LDL from the circulation and providing the cell with the necessary cholesterol.   
1.2.3 Transportation of sterols in body fluids and lipoprotein metabolism 
Cholesterol and other lipids are transported in body fluids in lipoproteins (Li and Parish, 
1998). Lipoproteins are particles consisting of a core of hydrophobic lipids surrounded by a 
shell of polar lipids and apoproteins. Lipoproteins are divided according to their densities 
into five major classes: chylomicrons, very low density lipoprotein (VLDL), intermediate 
density lipoprotein (IDL), low density lipoprotein (LDL) and high density lipoprotein 
(HDL) (Mensink et al., 1998). Each class has a characteristic lipid and apolipoprotein 
composition, particle size and density (Table 1).  
Table 1. Mean lipid compositions (relative amounts of lipids are expressed as %) and apoprotein classes of 
chylomicrons (CM), very low density lipoproteins (VLDL), intermediate density lipoproteins (IDL), low 
density lipoproteins (LDL) and high density lipoproteins (HDL)  (Mensink et al., 1998) 
COMPOSITION CM VLDL IDL LDL HDL
triglycerides 87 52 29 6 6
cholesterol esters 3 9 28 40 21
free cholesterol 2 6 7 9 3
phospholipids 6 23 22 22 24
apoproteins 2 10 14 23 46
ApoC-II ApoC-II ApoB-100 ApoB-100 ApoA-I
ApoE ApoE ApoE
ApoA-I
Core components
Surface components
Apoprotein class
 
Cholesterol absorbed by the intestine is secreted into the lymph and subsequently into the 
blood circulation in triglyceride-rich chylomicrons (CM) (Fig. 9) (Mensink et al., 1998). The 
chylomicrons are rapidly metabolised by lipoprotein lipase (LPL) and free fatty acids leave 
the chylomicrons. The resulting particle consisting mainly of cholesterol esters, called a 
chylomicron remnant (CMr), is removed from circulation by the liver. The liver excretes 
triglyceride-rich VLDL particles into the blood circulation. Similarly to chylomicrons, 
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 VLDL particles encounter LPL and some of the triglycerides leave the particle first 
forming IDL and then LDL particles. LDL particles are the major carrier of plasma 
cholesterol to extrahepatic tissues (Kesäniemi and Miettinen, 1988). Specific receptors in 
cells bind LDL with high affinity and the entire lipoprotein enters the cell by endocytosis. 
The removal of LDL cholesterol from circulation is mainly regulated by the activity of the 
LDL receptors in the liver. An additional pathway for LDL removal involves a process 
associated with scavenger cells or macrophages of the reticuloendothelial system. 
Apolipoprotein B (ApoB) has a central role in the metabolism of cholesterol (Kesäniemi 
and Miettinen, 1988). It is an essential structural component of VLDL and LDL 
lipoproteins and is a ligand that mediates the clearance of lipoprotein from circulation by 
LDL receptor pathway. The structural polymorphism of apoB may affect lipoprotein 
metabolism by still unknown mechanisms.  
intestine
CM
CMr
LPL
 liver
remnant 
receptor ApoB,E- 
receptor
VLDL
LPL
IDL
LDL HDL
dietary
cholesterol
extrahepatic 
tissuesremnant 
receptor
scavenger
pathway
ApoB,E- 
receptor
CETP
 
Figure 9. Cholesterol distribution and metabolism (modified from Mensink et al., 1998). (CM = 
chylomicron, CMr = chylomicron remnant, LPL = lipoprotein lipase, VLDL = very low-density 
lipoprotein particle, IDL = intermediate-density lipoprotein particle, HDL = high-density lipoprotein 
particle, CEPT = cholesterol ester transfer protein) 
Unlike LDL, HDL participates in reverse cholesterol transport, transferring 
cholesterol from tissues back to the liver (Fig. 9) (Robins and Fasulo, 1997). HDL binds 
cholesterol from extrahepatic tissues. Lecithin:cholesterol acyltransferase (LCAT) is a 
component of HDL particles that facilitates the esterification of cholesterol and trapping 
esterified cholesterol into the hydrophobic HDL core. HDL particles transfer the released 
cholesterol to LDL particles with the aid of cholesterol ester transfer protein (CETP) 
(Mensink et al., 1998). The cholesterol delivered to the liver by this pathway can 
subsequently be secreted into bile as cholesterol or bile acids. The formation of HDL in the 
liver requires a specific apoprotein A-I. The plasma concentration of apo A-I correlates 
highly with HDL levels and inversely with coronary risk. In addition to aiding the efflux of 
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 cholesterol from the artery wall, HDL exhibits other antiatherogenic features by carrying 
antioxidant enzymes (Libby, 2001).  
1.2.4 Hepatic sterol metabolism and secretion 
The input of cholesterol in hepatic cells comes from three sources: (1) chylomicrons, which 
carry the absorbed cholesterol from the intestine, (2) cholesterol synthesised from 
peripheral tissues and (3) cholesterol synthesised in the liver hepatocytes (Montet and 
Gerolami, 1978).  
Cholesterol is metabolised into three major classes of metabolic products: (1) the 
fecal neutral sterols, (2) bile salts and (3) steroid hormones and vitamin D (Li and Parish, 
1998). The neutral sterols and bile salts are quantitatively the most important excretory 
metabolites of cholesterol. Hepatic cholesterol may be transported to bile directly as free 
cholesterol in cholesterol-phospholipid vesicles (Ulloa et al., 1987). Bile salts are 
synthesised from cholesterol in the liver and secreted into bile as micellar solutions 
(Strasberg, 1998). Hepatic cholesterol may also be converted into cholesterol esters, which 
are either exported from liver to serum in lipoproteins or stored as such in the liver 
(Strasberg, 1998). 
1.3 PHASE BEHAVIOUR OF CHOLESTEROL AND ITS ROLE IN 
PATHOPHYSIOLOGICAL DEPOSITS 
1.3.1 Phase behaviour of pure cholesterol in the presence and absence of water 
Crystalline cholesterol is known to exist as anhydrated and monohydrated crystal forms. 
Anhydrated cholesterol crystals precipitate from supersaturated solutions in the absence of 
water and exhibit typically a needle-like crystal habit (Garti et al., 1981). The anhydrated 
crystal form of cholesterol undergoes an enantiotropic phase transition near a human body 
temperature and melts at 150°C (Spier and van Senden, 1965; Petropavlov and Kostin, 
1976; Hsu and Nordman, 1983). The crystal structure of anhydrous cholesterol is described 
by Shieh et al. (1977) and Hsu and Nordman (1983). 
Cholesterol may crystallise as cholesterol monohydrate crystals from supersaturated 
solutions in the presence of water (Garti et al., 1981). Monohydrated cholesterol does not 
undergo a polymorphic phase transition near 37°C like anhydrous cholesterol. In a closed 
system, cholesterol monohydrate loses its water of hydration at 80-85°C, forming a high 
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 temperature form of anhydrous cholesterol, which melts at 150°C (Loomis et al., 1979). In 
the presence of water anhydrous cholesterol form a liquid crystalline phase at ≈120°C. The 
liquid crystal phase is stable up to the melting temperature (150°C). The monohydrated 
cholesterol crystals are thermodynamically unstable at room temperature below 80% 
relative humidity and tend to lose their water of hydration. According to Craven et al. 
(1974) cholesterol monohydrate is a tunnel hydrate, which provides an explanation for the 
ease with the crystal dehydrate.  
1.3.2 Cholesterol solubility 
Cholesterol is practically insoluble in water (Saad and Higuchi, 1965) and thus it is 
associated with different vehicles in the human body. Cholesterol is either solubilised in 
bile salt micelles, associated with different phospholipid vesicles or lipoprotein particles as 
free cholesterol or as cholesterol fatty acids esters (Montet and Gerolami, 1978; Staggers et 
al., 1990; Mensink et al., 1998). 
Although the aqueous solubility of cholesterol is less than 10-7 M (Saad and Higuchi, 
1965), an appreciable amount (> 10-3 M) of cholesterol can be solubilised in aqueous bile 
salt and bile salt-lecithin solutions (Carey et al., 1981). The micellar solubility and 
dissolution rate of cholesterol anhydrate are higher than those of cholesterol monohydrate 
in bile salt and bile salt-lecithin systems (Mufson et al., 1972; Igimi and Carey, 1981). In the 
presence of water, cholesterol monohydrate seems to be the more stable lower-energy state 
of cholesterol.  
Phospholipid bilayers solubilise cholesterol with a cholesterol to phospholipid molar 
ratio of 1:1 or even higher (Huang et al., 1999; Yeagle, 1985). The phase behaviour of 
cholesterol-phospholid binary systems is studied by Presti and co-workers (Presti and 
Chan, 1982; Presti et al., 1982) and Recktenwald and McConnell (1981). 
According to phase behaviour studies by Dorset (1990) and Ekman and Lundberg 
(1976) cholesterol-cholesterol ester binary systems exhibit eutectic behaviour with 
negligible solid solubility. Similar phase separation has been observed with cholesterol-
triglyceride binary systems. The solubility of cholesterol in different edible oils varies from 
1-5% depending on the oil concerned (Stauffer and Bischoff, 1966; Wright and Presberg, 
1964). The addition of an aqueous phase results in a decrease in cholesterol solubility in the 
oil phase due to transformation of anhydrated cholesterol into a monohydrated form 
(Jandacek, 1977). 
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 1.3.3 Cholesterol in pathological deposits 
1.3.3.1 Atherosclerosis 
Atherosclerosis is characterised by thickening of arterial walls through accumulation of 
lipids in the inner layers (intima) of the arteries supplying blood to the heart, brain and 
other vital organs. These lesions obstruct the lumen of the vessel and result in ischaemia of 
the tissue supplied by the vessel. The development of atherosclerosis has been shown to be 
positively correlated to the level of cholesterol in plasma (Libby et al., 2000). 
Atherosclerotic plaques consist primarily of lipids such as cholesterol, cholesterol esters 
and phospholipids (Small and Shipley, 1974). Lipid deposition can be described in physico-
chemical terms, i.e. the progression of a lesion is characterised by phase diagrams of 
cholesterol, cholesterol esters and phospholipids in the presence of water (Small and 
Shipley, 1974; Dorset, 1987; Dorset, 1988; Dorset, 1990) (Fig. 10).  
Depending on 
the lipid composition 
of the plaques there 
are different phases 
present in the intima 
(Small and Shipley, 
1974). Initially (at early 
ages), the intima lipids 
are composed of liquid 
crystalline 
phospholipid bilayers 
unsaturated with 
cholesterol and 
cholesterol esters (Fig. 
10; Zone I). In the normal intima taken from males at the age of 15 to 20 years, the 
composition tends toward saturation of the phospholipid phase with cholesterol and 
cholesterol esters, but still only one single phase is present. With age, the normal intima 
contains relatively more cholesterol esters and two phases are found: liquid crystalline 
phospholipid phase saturated with cholesterol and oily phase composed of cholesterol 
esters (Fig. 10; Zone III). When intima lipids are supersaturated with cholesterol a solid 
Figure 10. The three-component phase diagram composing of free 
cholesterol (CHOL), phospholipids (PL) and cholesterol esters (CE) 
at constant water content (70%) (modified from Small and Shipley, 
1974) 
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 phase composing of free cholesterol as cholesterol monohydrated crystals is observed (Fig. 
10; Zone IV) (Bogren and Larsson, 1963; Lundberg, 1985).  
In addition to monohydrated cholesterol crystals, mixed crystals of cholesterol and 
cholestanol (dihydrocholesterol) have been found in atherosclerotic plaques (Boldrini, 
1979a; Boldrini, 1980). Cholestanol is one of the cholesterol oxidation metabolites, which 
can be found in vivo. Cholesterol and cholestanol will co-precipitate in the blood when the 
solubility of mixed crystals, cholesterol-cholestanol dihydrate, is reached. According to 
Hirch et al. (1988) the solubility of the cholesterol-cholestanol dihydrate in the blood is 
lower than that of either cholesterol or cholestanol. Thus, the presence of the mixed crystal 
may promote the nucleation of cholesterol by acting as a seed crystal. The quantity of 
cholestanol is 4 to 10 times higher in atherosclerotic plaques than in normal tissues 
(Boldrini, 1979a). 
The presence of calcium salts, such as hydroxyapatite, in atherosclerotic lesions have 
been found especially in the later stages of the pathological process (Hirsch et al., 1990). It 
has been established that an excellent crystallographic fit exists between cholesterol 
monohydrate and hydroxyapatite crystals. Thus, the epitaxial growth of the crystals is 
possible and either crystal may serve as a nucleus for the growth of the other.  The 
hydroxyapatite crystals are able to initiate cholesterol monohydrate and cholesterol-
cholestanol dihydrate crystallisation.  
1.3.3.2 Gallstones 
Gallstones are a very common problem in western societies: at the age of 75 years, 35% of 
women and 20% of men have gallstones (Ransohoff and Gracie, 1993). Cholesterol 
gallstones, which have been defined to contain at least 70% of cholesterol by weight, are 
the most common gallstones in western countries. The pathogenesis of cholesterol 
gallstone formation involves cholesterol supersaturaturation in bile, nucleation and growth 
of monohydrated cholesterol crystals and aggregation of small crystals into mature 
gallstones (Strasberg, 1998; Malá et al., 1998). 
Biliary lipids are composed of bile salts, phospholipids and cholesterol (Montet and 
Gerolami, 1978). The solubility of bile salts in water is 2-6 mM, and above this 
concentration bile salts aggregate as micelles. Phospholipids extracted from bile are 
insoluble in water and associate out of solution as liquid crystalline lipid bilayer vesicles 
(liposomes) in water. Cholesterol is practically insoluble in water, self-aggregates, and forms 
solid cholesterol monohydrate crystals (Saad and Higuchi, 1965; Gilbert et al., 1975, Gilbert 
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 et al., 1976). Depending on the proportions of these different lipids and the total lipid 
concentration in the aqueous phase, lipids form mixed micelles, liposomal vesicles, 
different liquid crystalline phases and/or crystalline cholesterol precipitates (Mazer and 
Carey, 1983; Armirand and Small, 1968) (Fig. 11).  
In bile, cholesterol crystallises as cholesterol monohydrate crystals (Bogren and 
Larsson, 1963; Wada et al., 1992). In addition to cholesterol monohydrate crystals, mixed 
crystals of cholesterol and cholestanol hav
Supersaturation does not 
guarantee stone formation b
e been found in gallstones (Boldrini, 1979b). 
ecause 
bile from healthy subjects is often 
supersaturated with cholesterol 
(Holzbach et al., 1973). The second 
stage of gallstone formation is 
crystallisation of cholesterol crystals 
from supersaturated bile (Strasberg, 
1998). There are two mechanisms 
which permit the crystallisation of 
cholesterol in bile (Kiviluoto et al., 
1994; Strasberg, 1998). The first is a 
gallbladder motility defect, which 
provides time for nucleation and 
crystal growth to occur. The second 
mechanism is a presence of procrystallising factors, which result in acceleration of 
crystallisation.  
Figure 11. Phase diagram with the relative lipid composition
in terms of cholesterol, lecithin and bile salts at constant water
concentration of 90% (modified from Admirand and Small,
1968) 
Gallstones are formed from floating cholesterol monohydrate crystals by aggregation 
(Strasberg, 1998). An innumerable number of cholesterol monohydrate crystals abruptly 
aggregate to form spheres up to 1 mm in diameter. Secondary aggregation into stones takes 
months or even several years. 
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 1.4 PLANT STEROLS AS CHOLESTEROL LOWERING AGENTS 
1.4.1 Absorption, distribution and elimination of plant sterols in the human body 
Plant sterols are not endogenously synthesised in the human body, but are consumed at 
levels of 200-400 mg/day in western diets, which is almost equal to the average dietary 
cholesterol intake (Jones et al., 1997). Dietary plant sterols consist mainly of β-sitosterol 
(approximately 80%), some campesterol and stigmasterol, and traces of saturated plant 
stanols. The main sources of plant sterols are vegetable oils, cereal grains and nuts. Plant 
materials contain free plant sterols, sterol esters of fatty acids or phenolic acids and sterol 
glycosides (Piironen et al., 2000).   
Plant sterols are poorly absorbed compared to cholesterol (Sylven et al., 1970). The 
increase in the side chain length of the sterol molecule leads to decreased intestinal 
absorption. The intestinal absorption of campesterol and β-sitosterol is 10% and 5% of the 
ingested amount, respectively (Heinemann et al., 1993; Salen et al., 1970; Vahouny et al., 
1983). The absorption of stigmasterol, which differs from β-sitosterol by unsaturation of 
the side chain, is equal to that of β-sitosterol. In respect to the sterol tetracyclic skeleton, 
saturation of the ring B reduces the efficiency of absorption as demonstrated by differences 
in absorbability of β-sitosterol and β-sitostanol (Hassan and Rampone, 1979; Sugano et al., 
1977) as well as cholesterol and cholestanol (Vahouny et al., 1960).  
Sitosterolemia is a rare inherited lipid storage disease, in which there is an apparent 
loss in the intestinal selectivity of absorbable and nonabsorbable sterols. Sitosterolemia is 
characterised chemically by the accumulation of plant sterols and stanols in plasma and 
other tissues (Salen et al., 1992). Recent studies suggest that sitosterolemic patients have 
mutations in two adjacent genes encoding proteins, which exclude cholesterol from other 
sterols in the human body, and thus the intestine fails to discriminate between cholesterol 
and plant sterols (Berge et al., 2000; Patel, 2001). These proteins (sterolin-1 and sterolin-2) 
are expressed in the liver and intestine, and work probably by preventing the initial entry of 
other sterols at intestinal level and by rapidly excreting any residual amounts that enter 
blood circulation into bile. 
Similarly to cholesterol, ingested free and esterified plant sterols are distributed 
between oil and aqueous micellar phases and hydrolyses of fat-soluble esterified sterols 
occur in the upper intestine (Miettinen and Siurala, 1971). The increase in hydrophobicity 
of plant sterols, compared to cholesterol, decreases the micellar solubility of plant sterols 
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 and causes a restriction in intestinal absorption (Armstrong and Carey, 1987). Although 
cholesterol exhibits a higher binding affinity to bile salt micelles, the solubilisation of β-
sitosterol in bile salt micelles is energetically more favoured than that of cholesterol. In 
addition, the desorption rate of β-sitosterol from phospholipid vesicles in vitro is lower 
than that of cholesterol (Kan and Bittman, 1991). This may restrict the dissociation of plant 
sterol from micelles near the brush border membrane. 
It is still unknown whether the discrimination between cholesterol and plant sterols 
takes place at the level of brush-border membrane or the intracellular processing of the 
sterols involving esterification and packaging of the sterols into chylomicrons (Compassi et 
al., 1997). The esterification of β-sitosterol by ACAT is inefficient compared with that of 
cholesterol, and this is thought to at least partly account for its poor absorbability in animal 
and human studies (Ikeda et al., 1988b; Field and Mathur, 1983; Field et al., 1997).  About 
90% and 12% of lymphatic cholesterol and β-sitosterol in chylomicrons is present as esters, 
respectively. 
 According to several studies (Salen et al., 1970; Boberg et al., 1990) some of the 
absorbed β-sitosterol is converted into polar acid products in bile and the rest is excreted in 
bile as free sterol. In healthy subjects, the liver preferentially secretes β-sitosterol in bile. 
Thus, β-sitosterol to cholesterol ratio is three times higher in bile than in plasma and the 
elimination of β-sitosterol is faster than that of cholesterol (Gould et al., 1969). 
Similarly to cholesterol, β-sitosterol is widely distributed in the human body (Gould 
et al., 1969). Plasma β-sitosterol is esterified to a similar extent (70%) to plasma cholesterol 
(Salen et al., 1970). LDL particles are the main carriers of plasma plant sterols and HDL 
particles are responsible for eliminating plant sterols from systemic circulation to liver to be 
excreted into bile (Kuksis, 2001; Robins and Fasulo, 1997).  
1.4.2 Effects of plant sterols  
1.4.2.1 Serum cholesterol lowering effect 
Plant sterols have lowered serum total and LDL-cholesterol levels under a wide range of 
different study conditions within the range of 0.5-26% and 2-33%, respectively (Jones et 
al., 1997). Neither plasma HDL nor triglyceride levels are affected by plant sterols 
consumption. A plant sterol or stanol dose of 0.8 g/day is needed to achieve a significant 
cholesterol-lowering effect and the effect increases by increasing the dose up to 3 g/day 
(Hallikainen et al., 2000b; Hendriks et al., 1999).  
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 β-sitosterol is the most predominant of the plant sterols and its hypocholesterolemic 
properties have been widely studied. Most available β-sitosterol products contain various 
amounts of other plant sterols and few studies have been performed with pure β-sitosterol 
or β-sitostanol.  The plant sterols used in clinical trials are composed of 47-93% β-
sitosterol, 5-33% campesterol and smaller amounts of other sterols and stanols (Lees et al., 
1977; Kudchodkar et al., 1976; Hendriks et al., 1999; Normen et al., 2000).  The plant 
stanols used in clinical trials are composed mainly of β-sitostanol (68-93%) with the rest of 
the mixture being mainly campestanol (Plat and Mensink, 2000; Plat et al., 2000; 
Hallikainen and Uusitupa, 1999; Hallikainen et al., 2000b; Heinemann et al., 1986; Normen 
et al., 2000). 
The reductions between 25% and 65% in cholesterol absorption by β-sitosterol 
(purity 93%) have been reported in man (Mattson et al., 1982). According to animal 
(Mattson et al., 1977) and human studies (Vahouny et al., 1983), the cholesterol absorption 
restricting effect of stigmasterol (purity 88% and 96%, respectively) is similar to that of β-
sitosterol (purity 87% and 96%, respectively). In addition, campesterol (purity 98%) has 
been reported to lower cholesterol levels in rats (Mattson et al., 1977).  
According to several experimental animal and human studies, the saturated form of 
β-sitosterol, β-sitostanol, is more effective than β-sitosterol in the inhibition of cholesterol 
absorption (Heinemann et al., 1988; Heinemann et al., 1991; Sugano et al., 1977, Ntanios 
and Jones, 1998). Heinemann et al. (1991) suggested than the greater effect of β-sitostanol 
could be due to its higher hydrophobicity and lower absorbability compared to β-sitosterol. 
However, in several human studies the serum cholesterol lowering effects of plant sterols 
and saturated plant stanols have been equal (Westrate and Meijer, 1998; Hallikainen et al., 
2000a) or the effect of plant sterols has been more effective compared to saturated plant 
stanols (Jones et al., 2000). 
1.4.2.2 Antiatherogenic effect 
The results of comprehensive drug intervention studies with cholesterol lowering drugs 
have demonstrated that cholesterol lowering reduces the risk of coronary events in a wide 
range of subjects (Levine et al., 1995; Sullivan, 2002). The magnitude of the reduction of 
CVD events is proportional to the amount of cholesterol lowering and the CVD risk in 
treated and non-treated patients with equivalent serum cholesterol levels is comparable 
(Bucher et al., 1999; Law et al., 1994).  
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 The anti-atherogenic effect of plant sterols is documented in mice (Moghadasian et 
al., 1997). Administration of plant sterols (69% β-sitosterol, 15% campesterol, and 16% 
stigmasterol) reduced the size of atherosclerotic lesions, and the effect correlated well with 
their cholesterol lowering effect.   
1.4.2.3 Safety of plant sterols 
Harmful clinical or chemical adverse effects have not been observed in clinical human 
studies with plant sterols and stanols (Ayesh et al., 1999; Plat et al., 1999; Plat and Mensink, 
2000). In theory, the administration of plant sterols and stanols in order to reduce 
cholesterol absorption could simultaneously interfere with the absorption of fat-soluble 
vitamins. In practice, reduced serum carotenoid concentrations, but not reduced vitamin D 
and retinol concentrations or α-tocopherol/cholesterol proportion, have been reported 
after the administration of plant sterols and stanols (Gylling et al., 1999b; Gylling and 
Miettinen, 1999; Hallikainen et al. 1999; Hendriks et al., 1999; Westrate and Meijer, 1998).  
Several plant sterols of dietary origin have been found in small quantities in plasma 
lipoproteins, human bile, and gallstones (Miettinen et al., 1986). In healthy subjects, the β-
sitosterol concentration in human serum is about 1/1000 of serum cholesterol 
concentration (Kuksis, 2001). The consumption of effective doses of β-sitosterol (0.8-3 
g/day) causes even a twofold increase in the serum β-sitosterol concentration (Westrate 
and Meijer, 1998). High serum plant sterol concentrations have been observed in patients 
suffering from sitosterolemia (Miettinen et al., 1980). Very high plasma concentrations of 
β-sitosterol may have potential cytotoxic effects and may interfere with cellular functions 
(Moghadasian and Frohlich, 1999). Similarly to cholesterol, high plasma plant sterol 
concentration has been found to be atherogenic (Glueck et al., 1991). Sitosterolemic 
patients, with abnormally high plasma plant sterols, develop tendom xanthomas, 
accelerated atherosclerosis and haemolytic episodes. According to animal studies, it has 
been suggested that high plasma concentrations of plant sterols may have adverse effects 
on reproductive organs (Malini and Vanithakumari, 1990, 1991 and 1992; Mellanen et al., 
1996). 
1.4.3 Proposed cholesterol lowering mechanisms of plant sterols 
It is generally assumed that the serum cholesterol lowering effect of plant sterols results 
from the inhibition of cholesterol absorption from the intestinal lumen (Moghadasian and 
Frohlich, 1999). The typical dietary intake of plant sterols is almost equal to the dietary 
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 intake of cholesterol (Ling and Jones, 1995). In addition to cholesterol from dietary 
sources, two thirds of the cholesterol present in the intestinal lumen is endogenous 
cholesterol from bile (Wilson and Rudel, 1994). When effective doses (1-3 g/day) of β-
sitosterol or plant sterols mixtures are consumed, the ratio of cholesterol to plant sterol 
entering the intestinal lumen is about 1:1. As well as inhibiting the absorption of 
cholesterol, plant sterols have been reported to have effects on enzymes involved in 
cholesterol metabolism (Ling and Jones, 1995; Moghadasian and Frohlich, 1999). 
1.4.3.1 Mixed crystal formation of β-sitosterol and cholesterol 
As early as in the 1950’s it was observed that cholesterol and β-sitosterol form a mixed 
crystal from which the two components cannot be separated by recrystallisation (Pollak, 
1953). Davis (1955) observed that cholesterol and β-sitosterol formed a new crystal form 
when 1:1 mixture of the sterols was precipitated from methanol. The solubility of the new 
crystal form in methanol was considerably lower than that of cholesterol but higher than 
that of β-sitosterol. Davis concluded that the conversion of cholesterol in the intestine into 
a less dispersible form by the formation of mixed crystal with sitosterol could be the 
primary mechanism by which cholesterol absorption is reduced. A later study confirmed 
that cholesterol and β-sitosterol form a solid solution at 1:1 molar ratio when crystallised 
from either methanol or ethanol (Karpuj et al., 1982).  
1.4.3.2 Restriction of the solubility of cholesterol in the intestinal oil and micellar phases 
According to the mechanism presented by Mattson et al. (1982), the absorbability of 
cholesterol is determined by the total sterol concentration (cholesterol plus plant sterols) in 
the intestinal fat. β-sitosterol reduces the solubility of cholesterol in oil presumably by 
competing for solubility sites (Wright and Presberg, 1964). When the sterol solubility in oil 
is exceeded, solid sterols crystals, which are not absorbed, precipitate. The composition of 
the precipitated sterols in the intestine reflects that of the oil phase. In the lumen of the 
intestine sterols are distributed between micellar and oil phases. The surface activity of the 
free sterols causes them to accumulate at the oil/water interface. At the interface, the 
transfer of the sterols to the micellar phase and their crystallisation are facilitated. Thus, 
high intake of plant sterol increases the faecal excretion of neutral sterols (Westrate et al., 
1999).  
According to Armstrong and Carey (1987), the binding of β-sitosterol to trihydroxy 
bile salt micelles is energetically favoured compared with cholesterol. Both β-sitosterol and 
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 β-sitostanol decrease the micellar solubility of cholesterol and reduce the concentration of 
cholesterol in mixed bile salt micelles, both in vitro and in vivo (Ikeda and Sugano, 1983; 
Ikeda et al., 1988a; Ikeda et al., 1989). In general, the competition for the micellar 
solubilisation capacity of bile salts may regulate the absorption of different sterols in the 
intestinal lumen. For example, plant stanols prevent the absorption of plant sterols in 
addition to cholesterol, resulting in a lowering of the respective serum levels of sterols, but 
even a twofold increase in serum plant stanol levels is observed (Gylling et al., 1999a; 
Gylling and Miettinen, 1999; Hallikainen et al., 2000a).  
1.4.3.3 Competitive inhibition of cholesterol uptake by intestinal mucosal cells 
The early studies suggested that β-sitosterol could restrict the absorption of cholesterol by 
competitive inhibition of the uptake by intestinal mucosal cells (Glover and Green, 1957). 
According to later studies, β-sitosterol does not affect the uptake of cholesterol from 
micellar solutions or the esterification of cholesterol by the mucosal cells (Ikeda and 
Sugano, 1983; Field et al., 1997). 
1.4.3.4 Effects on cholesterol synthesis and metabolism 
A feedback control of cholesterol synthesis is demonstrated to occur when cholesterol 
absorption is restricted by plant sterols or stanols (Grundy et al., 1969; Gylling et al., 1999a; 
Gylling and Miettinen, 1999). When the intestinal absorption of cholesterol is greatly 
reduced, a compensatory increase in the cholesterol synthesis is observed. 
Although intestinal mechanisms have been most widely accepted as responsible for 
cholesterol lowering actions of plant sterols, animal studies have suggested that 
intraperitoneal and subcutaneous injections of β-sitosterol also lower circulating cholesterol 
concentrations (Vanstone et al., 2001). The mechanism by which β-sitosterol acts in vivo is 
not known, but one suggested mechanism is that β-sitosterol alters the enzymes involved in 
cholesterol metabolism. β-sitosterol has been shown to reduce cholesterol synthesis and 
the activity of HMG-CoA reductase in vitro (Field et al., 1997). In addition, consumption 
of added β-sitosterol has been found to increase the LCAT level in blood (Weisweller et al., 
1984). LCAT is a component of HDL particles that facilitates the esterification of 
cholesterol and the trapping of esterified cholesterol into the hydrophobic HDL core. 
Conflicting results of the possible effects of plant sterols on enzymes responsible for 
conversion of cholesterol into bile acids (cholesterol-7α-hydroxylase) have been published 
(Ling and Jones, 1995). 
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 1.4.4 The effect of the dosage form of plant sterols 
Due to the possible mechanisms by which plant sterols inhibit the cholesterol absorption, a 
uniform and intimate mixture of plant sterols with the cholesterol containing mass in the 
intestine should be important. Thus, the preferred vehicle for plant sterols would be dietary 
fat, which is also a carrier for the dietary cholesterol (Mattson et al., 1982).  
Rather large doses of β-sitosterol, up to 3 g/day, are needed to achieve an effective 
lowering in serum cholesterol levels (Hallikainen et al., 2000b; Hendriks et al., 1999). In 
addition to the large doses, the physical properties of free plant sterols and stanols limit 
their applicability in food and several pharmaceutical oral preparations. Free plant sterols 
and stanols are crystalline materials, which are insoluble in water and their solubility in 
edible fats and oils is low (Mattson et al., 1977).  
The cholesterol absorption reducing effect of plant sterols seem to be dependent on 
the physical state of the plant sterols (Mattson et al., 1982). The clinical trials that showed 
the largest effects have used plant sterols and stanols in finely dispersed forms such as 
dispersed with food during cooking or esterified with fatty acids and dissolved in vegetable 
oil (Table 2). Comparison between different studies does not give reliable information on 
different dosage forms due to large differences in study conditions. 
Table 2. Examples of different dosage forms of plant sterols and stanols in clinical trials and the observed 
serum total cholesterol lowering effects 
FORMULATION DOSE / DAY EFFECT 1) REFERENCE
β-sitostanol oil suspension (25%) in capsules 3 g no significant effect 
(3 months)
Denke, 1995
β-sitostanol partially dissolved and suspended 
in oil in capsules
1.5 g - 15% (4 weeks) Heinemann et al ., 1986
Plant stanol suspended in food 1.5 g - 15% (30 days) Jones et al. , 1999
Plant sterol dispersed (particle size 130 µm) in 
food
1.25-5.0 g - 5% (15 weeks) Tikkanen et al. , 2001
Plant stanol esters in margarine 2.6 g - 10% (one year) Miettinen et al. , 1995
Plant sterol and stanol esters in margarine 0.8-3 g - 3-11% (4 weeks) Hallikainen et al. , 2000a and 
2000b
Plant stanol esters in margarine 8.6 g - 18% (21-28 days) Ayesh et al. , 1999
1) serum cholesterol levels calculated in reference to control  
Esterification of plant sterols increases the lipid solubility and thus provides a 
technically feasible way of introducing plant sterols into edible fats and oils (Wester, 2000). 
In theory, less soluble free crystalline plant sterols may enter the micellar phase less 
effectively than sterols released from fat-soluble sterol esters after their hydrolysis. It is 
proposed that in the intestine the plant sterol esters are hydrolysed and the resulting free 
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 sterols decrease the solubility of cholesterol in oil and micellar phases (Mattson et al., 
1977). Only a few comparative studies of free and esterified sterols have been performed. 
In an animal study with rats, no difference in the cholesterol lowering effects of free sterols 
and sterol esters was observed (Mattson et al., 1977). On the contrary, in a human study 
where the effect of free β-sitosterol was compared to the effect of esterified β-sitosterol, 
the free sterols resulted in a statistically significant 9% greater (42% versus 33%) decrease 
in cholesterol absorption than did the sterol ester form (Mattson et al., 1982). In that study, 
both the free and esterified sterols were dispersed in food. One possible explanation for 
the lesser effect of the ester form could be incomplete hydrolysation of the ester in the 
intestine.  
In a preliminary human study the efficacy of low dose β-sitostanol administered in 
lecithin micelles showed promising results compared to powdered β-sitostanol reducing 
cholesterol absorption by 37% (Ostlund et al., 1999b). Powdered β-sitostanol administered 
in capsules was ineffective in that study probably due to slow dissolution of solid stanol in 
bile. In another study sitostanol suspended in oil at a final concentration of 20% did not 
show any effect on LDL-cholesterol values during a 3-month trial with 3 g sitostanol / day 
(Denke, 1995).  
A preparation of submicron particles of β-sitosterol by precipitation in oil-in-water 
emulsion has been described in literature (Sjöström et al., 1993), but the cholesterol-
lowering effect of these sub-micron particles has not been published to our knowledge. In 
a recent study, the cholesterol lowering effect of a pulverised (< 130 µm) plant sterol 
preparation was rather modest in hypercholesterolemic subjects (Tikkanen et al., 2001). 
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 2 AIMS OF THE STUDY 
The poor solubility of plant sterols and stanols in oils and insolubility in water and 
relatively large daily doses limit their applicability in several preparations. This problem has 
been overcome by esterifying the sterols into fat-soluble esters, which provide a technically 
feasible way of introducing an adequate daily amount of plant sterols and stanols into 
several foods (Wester, 2000). Few efforts have been made to formulate a preparation 
suitable for oral administration of free crystalline plant sterols (Heinemann et al., 1986; 
Denke, 1995; Jones et al., 1999; Tikkanen et al., 2001). 
Few structural studies concerning free crystalline β-sitosterol or other plant sterols 
have been published (Bernal, 1940; Narayana Kalkura and Devanarayan, 1989). One 
proposed mechanism by which plant sterols reduce cholesterol levels is a formation of an 
unabsorbable mixed crystal in the intestinal lumen. In some studies, the mixed crystal 
formation of cholesterol and β-sitosterol at 1:1 molar ratio is described, but the 
crystallisation is performed only in the absence of water and only with few different 
cholesterol to β-sitosterol ratios (Davis, 1955; Karpuj et al., 1982). 
The aims of the present study were to develop a preparation suitable for oral 
administration containing β-sitosterol in free unesterified form and to understand the 
mechanism by which plant sterols interfere with cholesterol absorption. In order to achieve 
these goals 
- different pseudopolymorphic forms of β-sitosterol in the presence and absence of 
water were prepared and characterised, 
- the effects of different proportions of β-sitosterol, oil and water on the crystal size 
and other properties of suspensions were studied, 
- the cholesterol lowering effect of the prepared microcrystalline suspension was 
studied with hypercholesterolemic subjects and 
- the phase behaviour of β-sitosterol with cholesterol in both aqueous and non-
aqueous supersaturated solutions was characterised. 
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 3 EXPERIMENTAL 
Detailed descriptions of the materials and methods can be found in the respective original 
publications (I-IV). 
3.1 MATERIALS 
β-sitosterol (β-sitosterol for biochemistry) was purchased from Merck, Germany (I, III-IV) 
and from DRT (Les Dérivés Résiniques et Terpéniques), France (II). According to our 
GC-MS analyses, β-sitosterol from Merck contained 79% pure β-sitosterol and the rest of 
the product was composed of β-sitostanol (14%), campesterol (6%) and campestanol (1%). 
The used wood based β-sitosterol from DRT (II) was composed of β-sitosterol (75-80%), 
β-sitostanol (10-14%), campesterol and campestanol (6-11%) according to manufacturers 
specification. Cholesterol (III-IV) and β-sitostanol (III) were acquired from Sigma 
Chemical Company (St. Louis, MO, USA). According to our GC-MS analyses cholesterol 
was 99% pure and β-sitostanol contained 97% β-sitostanol and 3% campestanol. 
The used oils and solvents were MCT oil (I) (medium chain triglycerides, SHS 
International Ltd., UK), rapeseed oil (II) (Kultasula, Raisio, Finland), ethanol (III) 
(99.5%(v/v), Primalco Oy, Finland) and acetone (I, IV) (Analytical grade, Riedel-de Häen, 
Germany).  
3.2 PREPARATION AND ANALYSIS OF β-SITOSTEROL CRYSTALS (I) 
Anhydrous β-sitosterol was prepared by crystallising the sterol from supersaturated acetone 
and hydrated crystals from acetone-water 95:5 (v/v) mixture. Anhydrous crystals were 
dried at 80°C and stored over silica gel at 20 ± 2°C. Hydrated β-sitosterol were stored over 
a saturated solution of K2SO4 at 20 ± 2°C, which corresponded to 98% relative humidity.  
The water content of the crystals were analysed with a Karl-Fischer titrator (Mettler 
DL35, Mettler-Toledo Ag, Switzerland) and the thermal behaviour of the crystals was 
analysed using thermogravimetric analysis (TGA) with a Mettler TGA/SDTA analyser 
(model 851e, Mettler Toledo AG, Switzerland). 
Structural analyses of the crystals were performed using x-ray diffraction (XRD) and 
diffuse reflectance near infrared spectra (NIRS). XRD patterns were measured using a 
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 theta-theta diffractometer (Bruker AXS, Germany) with the angular range from 2o to 30o 
(2theta). Experiments were performed in a symmetrical reflection mode with CuKα 
radiation (1.54 Å) at 30 mA and 40 kV using Göbel Mirror bent gradient multilayer optics. 
The scattered intensities were measured with a scintillation counter.  
NIR spectra were measured using a Fourier transform (FT)-NIR spectrometer 
(Bomem MB-160 DX, Bomem Inc., Quebec, Canada). FT-NIR spectra of the samples 
were measured between 4000 and 10000 cm-1 with a resolution of 16 cm-1. Standard 
reflection was measured using a Teflon background (Labsphere, SRS-99-070, North 
Sutton, NH, USA). Spectral treatment was performed using Grams/32 software 
(Grams/32, version 4.04, Galactic Industries Corp., Salem, NH, USA).  
3.3 PREPARATION AND ANALYSIS OF β-SITOSTEROL SUSPENSIONS (I)  
Suspensions were prepared by cooling heated supersaturated solutions of β-sitosterol in 
MCT oil with simultaneous water addition. In preliminary studies, no clear differences were 
observed in β-sitosterol crystallisation between MCT oil and several edible oils including 
rapeseed and olive oils. Compositions of the studied plant sterol suspensions are presented 
in Table 3.  
Table 3. Compositions of the studied suspensions. The proportions of β-sitosterol, oil and water are 
presented as (w/w) % 
Composition β-sitosterol (%) Oil (%) Water (%)
20:80:00 20.0 80.0 0.0
20:80:01 19.8 79.2 1.0
20:80:05 19.0 76.2 4.8
20:80:10 18.2 72.7 9.1
20:80:15 17.4 69.6 13.0
10:80:05 10.5 84.2 5.3
05:80:05 5.6 88.9 5.6  
The solubility of anhydrous β-sitosterol in oil in the presence and absence of water at 
20°C was estimated by dissolving different sterol concentrations at 0.5% (w/w) intervals in 
oil and checking the presence of crystalline phase after 24 hours shaking using optical 
microscopy. 
The viscosity of the suspensions as a function of shear rate was measured with a 
cone and plate rheometer (Bohlin VOR Rheometer, Bohlin Reologi AB, Sweden) at 20°C.  
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 The crystal sizes and shapes of suspension particles were evaluated using optical 
microscopy. The structural analyses of the suspensions were performed using XRD and 
NIRS as described in chapter 3.2. 
3.4 CHOLESTEROL-LOWERING EFFECT OF MICROCRYSTALLINE β-
SITOSTEROL SUSPENSION IN HYPERCHOLESTEROLEMIC SUBJECTS 
(II) 
The cholesterol-lowering effect of a microcrystalline plant sterol suspension in oil was 
studied with hypercholesterolemic (serum total cholesterol concentration ≥ 5.8 mmol/l) 
subjects. The study protocol was approved by the Human Ethical Committee of the 
Faculty of Agriculture and Forestry, University of Helsinki and by the Ethical Committee 
of the Oulu Deaconess Institute, in Finland. Totally 155 selected subjects (100 women and 
55 men) with serum total cholesterol concentration ≥ 5.8 mmol/l, triglyceride 
concentration < 3 mmol/l participated in the study.  
This double-blind randomised, placebo-controlled study consisted of a 6-week run-
in period and a 6-month experimental period (Fig. 12).  
run-in 
period 
experimental period                  habitual 
diet 
= blood sample
= control spread
= 1.5 g plant sterols / day
= 3.0 g plant sterols / day
0 6-1½ +1½3 months
 
 Figure 12. The outline of the placebo-controlled intervention study 
All subjects received control spread, rapeseed oil based margarine, during the run-
in period. At the end of the run-in period, the subjects were randomly assigned in three 
groups: the control group continued to use the control margarine, the second group used 
margarine with added plant sterols 1.5 g/d and the third group used margarine with added 
plant sterols 3.0 g/d. The plant sterol concentrations of the test margarines were fortified 
by mixing different amounts of microcrystalline plant sterol suspension in rapeseed oil with 
the control margarine. The double-blind dietary testing period lasted for 6 months and 
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 there were three control visits during that period (0, 3 and 6 months’ visits). Six weeks after 
the subjects had finished eating study margarine and had returned to their habitual diet, the 
subjects were invited to attend the last control visit. 
Blood samples were taken at the beginning of the run-in and the experimental diet 
periods and at 3 and 6 months after randomisation. The post treatment blood samples 
were taken 6 weeks after the study was ended. Serum total cholesterol (CHOL), low-
density lipoprotein (LDL) and high-density lipoprotein (HDL) and triglyceride 
concentrations were determined from all the blood samples. Routine blood chemistry 
blood samples (including hemoglobin concentration, white blood cell count, red blood cell 
count, platelet count, hematocrit, serum tyrotropin and serum glucose) were analysed at the 
beginning of the run-in period and at the end of the experimental period to assess possible 
adverse effects of margarine consumption. In addition, serum concentrations of lipid 
soluble vitamins (retinol and α-tocopherol) and carotenoids (α- and β-carotene) were 
analysed at the beginning and at the end of the experimental period. Serum plant sterol and 
ubiquinol-10 concentrations, the amount of baseline diene conjugation in circulating LDL 
(LDL-BDC) and the antioxidant potential of LDL (LDL-TRAP) (Ahotupa et al., 1996; 
Ahotupa et al., 1998) were analysed of randomly selected 60 persons.  
7-day food diaries were kept by half of the participated subjects.  The first was at the 
beginning of the study (home diet), the second during the run-in period before 
randomisation, and the third was kept during the experimental period. Body weight, blood 
pressure and resting pulse were recorded on every visit.  
Analysis of variance (ANOVA) was used for the hypothesis testing. P-values are 
given to the differences of cholesterol levels between different study groups. P-values less 
than 0.05 for the differences between the mean values are considered statistically 
significant.  
3.5 PHASE BEHAVIOUR OF CHOLESTEROL WITH β-SITOSTEROL (III-
IV) 
3.5.1 Co-precipitates from ethanol (III) 
In the first study, β-sitosterol-cholesterol and β-sitostanol-cholesterol binary mixtures at 5-
10% weight-fraction intervals were precipitated from ethanol by solvent evaporation at 40 
°C. The resulting solids were further dried overnight in a freeze dryer.  
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 The thermal behaviour of the precipitates was analysed with a differential scanning 
calorimeter (DSC) model 910S (TA Instruments Inc., New Castle, DE, USA) from 30 to 
160°C at a heating rate of 5°C/min. Samples were weighed in crimped aluminium pans and 
similar empty pans were used as references.  
Samples at 20% intervals were analysed using small-angle (SAXS) and wide-angle x-
ray scattering (WAXS) methods. In the SAXS analyses, the samples were packed between 
thin polyimide foils and the samples were warmed from 30°C to the melting temperature 
of each co-precipitate and cooled back to 30°C at intervals of 10°C. The wide-angle x-ray 
scattering (WAXS) experiments were performed with a Seifert theta-theta diffractometer in 
symmetrical reflection mode with CuKα radiation (1.54 Å) selected with a graphite 
monochromator in the scattered beam. The scattered intensities were measured with a 
scintillation counter. The angular range was from 2o to 30o with the steps of 0.025o and the 
measuring time was 15 s/step.  
3.5.2 Co-precipitates from acetone and acetone-water (IV) 
Cholesterol, β-sitosterol and 3:1, 1:1 and 1:3 mixtures of these were co-precipitated from 
acetone and acetone-water solutions.  Sterols were precipitated from acetone and acetone 
water solutions as described in chapter 3.2. 
The solubilities of the sterols were determined with GC-MS from the clear 
supernatant after removing the precipitated crystals by filtering.  
The crystal habits of the sterol crystals were evaluated using optical microscopy. 
Thermal behaviour of the crystals were analysed using DSC as described in chapter 3.5.1. 
Crimped aluminium pans were used for anhydrous crystals and crimped pans with a few 
holes in the pan lid for hydrous crystals. Similar empty pans were used as references.  
X-ray diffraction patterns of the crystals were measured using a theta-theta 
diffractometer and the water content of the crystals precipitated from acetone-water 
solutions was analysed with a Karl-Fischer titrator as described in chapter 3.2. 
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 4 RESULTS AND DISCUSSION 
4.1 CRYSTAL FORMS OF β-SITOSTEROL (I,IV) 
β-sitosterol was observed to exist in three different crystal forms with different water 
contents: anhydrous, hemihydrated and monohydrated crystals (I, IV). The presence of 
three different forms was proved by several methods including XRD, NIRS, 
thermoanalytic methods (TG and DSC) and Karl-Fisher titrimetry. 
4.1.1 Anhydrous β-sitosterol 
Anhydrous β-sitosterol crystals, with elongated lath-shaped crystal habits, were formed 
when the sterol was crystallised from either acetone or oil in the absence of water. The x-
ray diffraction pattern of anhydrous β-sitosterol crystallised from dry acetone included six 
major reflections corresponding to Bragg distances of 17.6, 11.7, 8.80, 7.07, 5.87, 5.23 and 
3.92 Å (I, Fig.1). To our knowledge, the lattice parameters of anhydrous β-sitosterol have 
not been published. During heating anhydrous β-sitosterol did not undergo any phase 
transitions before melting at 138°C (IV, Fig. 3).  
4.1.2 Hydrated β-sitosterol 
In the presence of water, β-sitosterol precipitated from acetone and oil solutions as needle-
shaped crystals, which contained 1 mol water per 1 mol sterol according to the Karl-Fisher 
analyses (I, Table 2). The structure of these monohydrated crystals differed clearly from 
that of anhydrous form as the diffraction patterns were different (I, Fig.1). The main 
reflections of the x-ray pattern corresponded to Bragg distances of 17.6, 11.7, 7.05, 5.86, 
5.03, 4.81, 4.56 and 3.92 Å.  
The thermogravimetric curve of β-sitosterol monohydrate showed that the 
dehydration was a two-step process (I, Fig. 2). In the first phase (up to 60°C), 
approximately half of the water of crystallisation left the crystal and a hemihydrated 
structure was formed. The crystal structure of these hemihydrated crystals differed from 
both anhydrous and monohydrated β-sitosterol crystals (I, Fig.1 and 3). The main peaks in 
the x-ray patterns corresponded to Bragg distances of 18.8, 12.4, 7.45, 6.22, 5.90, 5.70, 5.32, 
5.05, 4.81, 4.74 and 4.61 Å. Further heating the hemihydrated crystals up to 90°C 
completed the dehydration and resulted in the formation of anhydrous crystals.  
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 The monohydrated form was observed to be stable at room temperature (20 ± 2°C) 
when stored at 98% relative humidity, but started to lose water of hydration even when 
stored in ambient relative humidity conditions. Similarly, cholesterol monohydrate crystals 
are known to be thermodynamically unstable and tend to lose their water of hydration at 
room temperature (Garti et al., 1981). In cholesterol monohydrate crystals, hydrogen 
bonded water molecules form pleated sheets (Craven, 1974). The early onset of 
dehydration during heating is characteristic of channel hydrate dehydration (Morris and 
Rodrigues-Hornedo, 1992). Migration of water molecules along the tunnels, where they lie, 
can provide an explanation for the ease with which the monohydrate crystals dehydrate.  
The more stable hemihydrated β-sitosterol crystals were formed when monohydrated 
crystals were dried in a desiccator over silica gel or heated up to 60 °C.  
The NIR spectrum of different pseudopolymorphic crystal forms of β-sitosterol 
differed clearly in the 1850-2000 nm region. Anhydrous crystals showed no absorbance in 
this region. Monohydrated β-sitosterol crystals exhibited two distinct peaks and thus 
revealed the presence of two different energetic states of water. The water peak observed 
with the higher wavelength (maxima at 1949 nm) and thus lower energy was not observed 
in the NIR spectrum of hemihydrated crystals. 
4.2 β-SITOSTEROL SUSPENSIONS IN OIL (I) 
4.2.1 Solubility of β-sitosterol in oil 
β-sitosterol is practically insoluble in water. The solubility of β-sitosterol in MCT-oil was 
observed to be between 3.5-4.0% (w/w) and 1.5-2.0% (w/w) when water was present. The 
decrease in the solubility of sterols in oil in the presence of water is due to the formation of 
hydrated sterols, which have lower solubilities in oil (Jandacek et al., 1977).  
4.2.2 Structure and viscosity of the suspensions 
Due to the low solubility of β-sitosterol in oil, the oil phase was saturated and crystalline β-
sitosterol particles were formed in all the studied compositions containing β-sitosterol, oil 
and water. The XRD patterns of the suspensions included reflections of crystalline β-
sitosterol and an amorphous background from the oil phase (I, Fig. 8 and 9).  
The composition of β-sitosterol suspension in oil affected the crystal size and shape 
of the suspended sterol particles and the viscosity of the suspension (I, Fig. 5, 6 and 7). In 
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 the absence of water, plate-like anhydrous particles were formed and the suspension 
exhibited nearly newtonian flow behaviour with only a slight decrease in viscosity due to an 
increase in the shear rate. Platelets tend to align easily in the direction of the applied shear 
and thus the viscosity of the suspension was rather low (Pena et al., 1995). Addition of 1% 
water to the composition resulted in the to formation of partially hydrated sterol crystals, 
but did not affect the suspension viscosity. Addition of 5-13% water to the composition 
resulted in the formation of monohydrated needle-shaped crystals. The viscosities of the 
suspensions containing needle-shaped particles were remarkably higher compared to the 
anhydrous suspension, but the viscosity decreased dramatically with increasing shear rate. 
Elongated particles tend to aggregate into clusters and demonstrate restricted rotational 
motion, which produce greater viscosity compared to the anhydrous suspension (Pena et 
al., 1995; Zitoun et al., 2001). With increasing shear rates, elongated particles tend to align 
along the flow and thus the viscosity decreased. 
The length of the needle-shaped monohydrated crystals decreased with increasing β-
sitosterol concentration (I, Fig. 7). High sterol concentration resulted in high 
supersaturation and thus formation of small crystals. The suspended particles were smallest 
(particle length ≈ 10 µm) when the β-sitosterol concentration was around 20% and the 
water concentration varied from 5 to 13%. Obviously, the best composition for oral 
treatment of hypercholesterolemia would be the one containing the smallest crystals. Small 
crystals result in the high free surface area of β-sitosterol crystals and thus facilitate the 
saturation of the sterol solubility in the intestinal lumen and interference with cholesterol 
absorption. 
4.3 CHOLESTEROL LOWERING EFFECT OF MICROCRYSTALLINE β-
SITOSTEROL SUSPENSION (II) 
The study started with 155 hypercholesterolemic volunteers, 55 males and 100 females. Of 
the subjects, 21 voluntarily withdrew from the study for a variety of reasons. In this study, 
the subjects consumed the test spreads as a part of their normal diet and lifestyle. The 
intakes of dietary cholesterol, total fat and hard fat, monounsaturated, and polyunsaturated 
fatty acids were similar in the three study groups and resembled closely that of a normal 
Finnish diet. 
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 4.3.1 Cholesterol lowering effect 
At the beginning of the experimental period the average serum total-, LDL- and HDL-
cholesterol levels were 6.66 ± 0.82 mmol/l, 4.29 ± 0.75 mmol/l and 1.75 ± 0.39 mmol/l, 
respectively. Total and LDL-cholesterol concentrations decreased significantly after the 
consumption of the plant sterol enriched spreads, but not after the consumption of the 
control spread (II, Fig. 1). Serum HDL-cholesterol and triglyceride concentrations were not 
affected by the consumption of the test and control spreads. When the microcrystalline 
suspension was consumed as a part of a normal diet, serum total and LDL-cholesterol 
concentrations reduced by 0.46-0.62 mmol/l (7.5-11.6%) compared to the values of the 
control group. In accordance with earlier studies with esterified plant sterols and stanols, 
the effect was achieved within 3 months’ consumption and the effect remained until the 
consumption was stopped (Miettinen et al., 1995).  
The cholesterol lowering effect of the microcrystalline plant sterol suspension was 
comparable to the previously reported effects of fat-soluble esterified plant sterols and 
stanols (Table 2). The maximum effect was achieved with a daily dose of 1.5 g and the 
higher dose (3 g/day) did not induce any further decrease in cholesterol levels. In earlier 
studies with esterified plant sterols and stanols the increasing dose provides a slight 
increase in the effect (Hendriks et al., 1999; Hallikainen et al., 2000b). Due to the 
microcrystalline structure of this ingredient, the effective surface area of the plant sterol 
crystals is large and thus a highly effective trapping of cholesterol molecules is achieved in 
the intestinal lumen. Because plant sterols are in free form, no hydrolysis is required before 
this effect can be achieved (Mattson et al., 1982). 
In a preliminary study, the effects of the microcrystalline β-sitosterol suspension 
containing 17% plant sterols, 70% oil and 13% water, and powder form β-sitosterol were 
compared in genetically obese rats (Summanen et al., 2000). Dietary plant sterol 
supplements were given with a concurrent high cholesterol diet. At the end of the 12-week 
study the rats consuming microcrystalline plant sterol suspension and powder form plant 
sterol supplement had 35% (p<0.001) and 25% (p<0.05) lower serum cholesterol 
concentrations than the control group, respectively. The results suggest that the particle 
size of crystalline plant sterol can have a marked impact on the cholesterol lowering effect.  
4.3.2 Side effects 
Serum β-sitosterol levels of the subjects consuming the β-sitosterol suspensions were 
observed to increase almost twofold, which is in accordance with earlier studies (II, Table 
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 2) (Westrate and Meijer, 1998). No effects of the test suspensions on serum lipid soluble 
vitamins, serum carotenoid concentrations, blood clinical chemistry or body mass indexes 
were observed (II, Tables 4 and 5). 
4.4 PHASE BEHAVIOUR OF CHOLESTEROL WITH β-SITOSTEROL (III-
IV) 
Phase behaviour of cholesterol and β-sitosterol can play an important role when both the 
sterols are present in physiological environments such as intestinal lumen, human plasma 
and bile. In the present studies, the effect of variable proportions of β-sitosterol on 
cholesterol precipitation and solubility was studied.   
4.4.1 Solid solubility of cholesterol and β-sitosterol 
Cholesterol and β-sitosterol exhibited solid solubility in a wide range of different 
cholesterol proportions when precipitated from ethanol by a solvent evaporation method 
(III) or from acetone and acetone-water solutions by lowering the temperature of the 
saturated solutions (IV). 
4.4.1.1 Co-precipitates from ethanol (III)  
Cholesterol as well as β-sitosterol may crystallise as hemiethanolate crystals when 
precipitated from ethanol (Garti et al., 1981; Karpuj et al., 1982). In our study, ethanol was 
evaporated quickly with a vacuum dryer and the remaining crystals were dried overnight in 
a freeze dryer. The crystal structure of the precipitated cholesterol was in accordance with 
earlier studies with anhydrous cholesterol (Hsu and Nordman, 1983). The crystals 
containing ≥ 20% β-sitosterol, exhibited a broad endothermic phase transition below 100°C 
indicating desolvation of the solvent from the crystals (III, Fig. 6 and 7). Thus, ethanol was 
more tightly bound to β-sitosterol crystal structure than to cholesterol crystals.  
The new crystal form, a solid solution of the sterols, dominated the crystal structure 
of sterol mixtures, especially when the proportions of the sterols were almost equal (III, 
Table I and Fig. 2,3,4 and 5). The thermal behaviour of the solid solutions differed from 
that of the starting materials as no phase transitions were observed before melting when 
the cholesterol proportion was > 0.2 (III; Fig. 7). With the cholesterol proportion of 0.2, 
the crystal structure of β-sitosterol dominated and the binary system had a melting point 
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 minimum. The presence of a melting point minimum revealed the eutectic behaviour of the 
system with the low cholesterol proportions. 
4.4.1.2 Co-precipitates from acetone and acetone-water (IV) 
When cholesterol, β-sitosterol and mixtures of these where precipitated from acetone and 
acetone-water solutions, the solid solubility of the sterols was observed except in low 
cholesterol proportions (< 20%). From dry acetone, both the sterols and sterol mixtures 
precipitated as anhydrous crystals. In the presence of water, cholesterol, β-sitosterol as well 
as mixed crystals precipitated as monohydrated crystals.  
The physical properties, such as melting point, crystal structure and habit of the solid 
solution of cholesterol and β-sitosterol varied with composition. The crystal structure of 
the solid solutions differed from that of the starting materials and was clearly different in 
the presence and the absence of water (IV; Fig. 4 and 7). The melting points of the 
anhydrous and monohydrated solid solutions decreased with the increasing proportion of 
β-sitosterol (IV; Fig. 3 and 6). The enantiotropic phase transition typical of anhydrous 
cholesterol at 37°C was not observed in the solid solutions or in the anhydrous β-sitosterol 
crystals. In the DSC experiments the dehydration of hydrated solid solutions occurred at 
lower temperatures than the dehydration of β-sitosterol. Because the dehydration of 
hydrated crystals in DSC analyses is highly dependent on the several factors (Giron, 1995) 
further studies are needed to confirm the differences in dehydration behaviours.  
Anhydrous cholesterol, β-sitosterol and mixed crystals exhibited all rather a similar 
elongated plate-like crystal habit, which has previously been reported for anhydrous 
cholesterol (IV; Fig. 2) (Shieh et al., 1977; Garti et al., 1981). Monohydrated cholesterol 
crystals had a typical lath-shaped crystal habit for monohydrated cholesterol (IV; Fig. 5) 
(Loomis et al., 1979; Garti et al., 1981). The monohydrated β-sitosterol precipitated as thin 
needle-shaped crystals and the crystal habits of the mixed crystals varied with composition. 
Both cholesterol and β-sitosterol crystallise in the similar way from supersaturated oil 
solutions as from acetone forming anhydrous crystals in the absence of water and hydrated 
crystals in the presence of water (Jandacek et al., 1977). Thus, co-precipitation could be 
expected to occur in the oily phase and at the interface of oily and aqueous phases in the 
intestinal lumen in the same way as in the present study. In addition, co-precipitation of 
cholesterol with plant sterols may occur in atherosclerotic plaques and bile. 
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 4.4.1.3 Cholesterol-β-sitosterol vs. cholesterol-β-sitostanol co-precipitates (III) 
Although there are only small differences in the molecular structures between β-sitosterol 
and β-sitostanol, their co-precipitates with cholesterol have quite different phase 
behaviours. While the cholesterol-β-sitosterol binary system exhibited solid solubility (III; 
Fig. 7), the cholesterol-β-sitostanol binary system exhibited phase separation with eutectic 
behaviour with only negligible solid solubility (III; Fig. 8). The molecular sizes and shapes 
of β-sitosterol and cholesterol must be similar enough to allow the formation of a solid 
solution (Kitaigorodsky, 1984).  
The different phase behaviour of β-sitosterol and β-sitostanol with cholesterol 
questions the importance of mixed crystals formation in the mechanism by which plant 
sterols and stanols restrict the absorption of cholesterol in the intestine since the 
cholesterol lowering effect of plant sterol and stanols is equal (Hallikainen et al., 2000a; 
Jones and Ntanios, 1998). However, there is also a clear difference in the physiological 
behaviour of plant sterols and stanols such as different absorbability from the intestine 
(Jones et al., 2000).  
4.4.2 Solubilities of cholesterol, β-sitosterol and mixed crystals in non-aqueous 
and aqueous organic solvent (IV) 
In the absence of water, the solubility of cholesterol-β-sitosterol binary mixtures in acetone 
did not differ from that of pure cholesterol, though the solubility of β-sitosterol was 
slightly lower than that of cholesterol (IV; Fig. 1a). In the presence of water, the solubility 
of cholesterol as well as that of β-sitosterol was considerably lower than in the absence of 
water (IV; Fig. 1b). The decrease in solubility was even greater with the more hydrophobic 
β-sitosterol. In the aqueous solutions, the solubility of the binary mixtures decreased with 
increasing β-sitosterol concentration. This phenomenon may be physiologically important, 
because in biological systems water is present. 
The significantly lower solubility of β-sitosterol compared to cholesterol in an 
aqueous environment results in a proportionally greater amount of β-sitosterol in the 
crystal phase than in the overall system (IV; Table 1). The presence of less soluble β-
sitosterol can induce the crystallisation of cholesterol by acting as a seed crystal.  Thus, the 
presence of β-sitosterol can facilitate the nucleation of cholesterol in physiological 
environments. Theoretically, if large amounts of plant sterols are absorbed such as in 
sitosterolemic patients, plant sterols could facilitate the formation of atherosclerotic 
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 plaques and gallstones in bile. In the lumen of intestine, the co-precipitation of dietary 
plant sterols and cholesterol may lead to restricted absorption of cholesterol and thus 
decrease in serum cholesterol levels.  
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 5 CONCLUSIONS 
In the present study, β-sitosterol was observed to exist in three different 
pseudopolymorphic forms with different water contents: anhydrous, hemihydrated and 
monohydrated crystals. To our knowledge, different pseudopolymorphic hydrates of β-
sitosterol have not been previously published. In the absence of water, β-sitosterol 
precipitated as anhydrous plate-like crystals in supersaturated acetone and oil solutions. 
Needle-shaped monohydrated crystals were formed in acetone and oil solutions in the 
presence of water. Hemihydrated crystals were formed when monohydrated crystals were 
partially dehydrated.  
Previously, few efforts have been made to formulate preparations suitable for oral 
administration of free crystalline plant sterols. In this study, preparation of a novel 
microcrystalline β-sitosterol suspension in oil is described. β-sitosterol suspensions in oil 
were prepared by adding water to supersaturated sterol in oil solutions. By changing both 
the sterol and the water concentration of the suspension, the crystal size and shape was 
controlled. Adding water to the composition resulted in the formation of monohydrated 
needle-shaped crystals instead of plate-like anhydrous crystals. High sterol concentration 
resulted in high supersaturation and thus in formation of small microcrystalline crystals. 
Microcrystalline β-sitosterol suspension in oil lowered effectively serum cholesterol levels 
in hypercholesterolemic subjects and the effect was comparable to earlier results with fat-
soluble esterified plant sterols and stanols. In earlier studies with esterified plant sterols and 
stanols an increase in the dose (up to 3 g/day) provides a slight increase in the effect. In the 
present study, the maximum effect was achieved with a daily dose of 1.5 g and a higher 
dose (3 g/day) did not induce any further decrease in cholesterol levels.  
β-sitosterol and cholesterol were observed to exhibit solid solubility over a wide 
range of different proportions. Previously, the solid solubility of cholesterol-β-sitosterol 
binary system at 1 to 1 molar ratio has been reported. In the present study, the formation 
of mixed crystals in the aqueous environment was described for the first time. Cholesterol, 
β-sitosterol, as well as the mixed crystals formed anhydrous crystals in the absence of water 
and monohydrated crystal in the presence of water. The present study supports the theory 
which suggests that β-sitosterol prevents cholesterol absorption by reducing its solubility in 
the intestinal lumen. The presence of β-sitosterol significantly decreased the total sterol 
solubility of the cholesterol-β-sitosterol binary mixture in the aqueous system. Thus, the 
presence of β-sitosterol can facilitate the nucleation of cholesterol in physiological 
environments. In the lumen of intestine co-crystallisation of sterols may lead to restricted 
absorption of cholesterol and thus cause a decrease in serum cholesterol levels.  
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